What Is Conjugated Linoleic Acid (CLA)?

Conjugated linoleic acid, usually called CLA, is a naturally occurring fatty acid found primarily in meat and dairy from ruminant animals like cattle, sheep, and goats. It belongs to the omega-6 family of fats but behaves quite differently from the linoleic acid in vegetable oils. CLA earned widespread attention starting in the late 1980s when animal research suggested it could reduce body fat and inhibit tumor growth, and it has since become one of the more popular weight-loss supplements on the market. The reality, though, is more complicated than the supplement labels suggest, and which form of CLA you take turns out to matter enormously.

Where CLA Comes From

CLA is produced naturally inside the digestive systems of ruminant animals. Bacteria in their stomachs convert regular linoleic acid from plant matter into various CLA isomers during fermentation. Because this conversion depends on the animal’s diet, the amount of CLA in beef or dairy varies dramatically based on how the animal was raised. Grass-fed cattle produce substantially more CLA than grain-fed animals, along with more of CLA’s precursor, trans-vaccenic acid, which your own body can convert into CLA after you eat it.¹ Research on Portuguese beef cattle confirmed this pattern, finding that pasture-fed animals had meaningfully higher levels of CLA isomers and omega-3 fats regardless of how much intramuscular fat the meat contained.²

Dairy products tend to be the richest dietary sources. Full-fat milk, cheese, butter, and yogurt from grass-fed cows all contain appreciable amounts, with cheese and butter topping the list on a per-serving basis. Lamb and beef follow, with smaller amounts in veal and turkey. That said, dietary intake from food alone typically lands in the range of tens to a few hundred milligrams per day for most people, far below the multi-gram doses used in supplement studies. This gap between food-level and supplement-level doses is one reason the two contexts often produce different outcomes.

Why the Isomer Matters

CLA is not a single molecule. It is a family of related fatty acids that share the same chemical backbone but differ in the exact position and orientation of their double bonds. Two isomers dominate both the research and the supplement market. The first, called cis-9, trans-11 CLA (often shortened to c9,t11), is the form found most abundantly in natural food. It makes up roughly 80 to 90 percent of the CLA in dairy and meat. The second, called trans-10, cis-12 CLA (t10,c12), occurs naturally at much lower levels but is present in large amounts in most commercial CLA supplements, which are synthetically produced from sunflower or safflower oil.

This distinction is not academic. The two isomers have genuinely different biological effects. Most of the fat-loss activity in studies has been attributed to the t10,c12 form, but that same isomer is also the one linked to worrying metabolic side effects, including insulin resistance and inflammatory markers. The c9,t11 isomer appears to be more benign and may even carry some unique benefits. Supplement blends typically contain a roughly 50/50 mixture of both, which means you are getting a very different CLA profile than what you would get from a steak or a glass of milk.

CLA and Body Fat

The fat-loss claim is what drives most CLA supplement sales, and there is some truth to it, though the effect is modest. CLA has been identified as a potential anti-obesity agent with strong effects in mice but more limited results in people.³ A meta-analysis of human trials estimated that at a typical dose of about 3.2 grams per day, CLA produced a fat loss of roughly 0.09 kilograms per week compared to placebo.⁴ That works out to less than a fifth of a pound per week, which over months could add up to a few pounds but is far from the dramatic transformation that marketing materials sometimes imply.

The proposed mechanisms involve several pathways. CLA appears to boost the breakdown of stored fat while reducing the accumulation of new fat in adipose tissue. Research suggests it may lower the activity of lipoprotein lipase, an enzyme that helps fat cells absorb fatty acids from the bloodstream, while increasing the activity of enzymes involved in burning fat for fuel. It may also interact with receptors that regulate how fat cells develop and influence the expression of proteins involved in generating heat from fat.⁵ Animal research has shown that CLA can activate brown fat thermogenesis and promote the “browning” of white fat, with increases in the heat-generating protein UCP1 in both brown and white fat tissue.⁶ Whether these thermogenic effects translate meaningfully to humans at typical supplement doses remains less clear.

The Insulin Resistance Problem

This is arguably the most important thing a potential CLA user needs to know, and it is routinely under-discussed. Multiple clinical trials have found that the t10,c12 isomer of CLA can worsen insulin sensitivity and raise blood sugar, particularly in people who are already metabolically vulnerable.

In one trial involving obese men with metabolic syndrome, the t10,c12 isomer alone increased insulin resistance by about 19 percent and raised fasting blood sugar by about 4 percent compared to placebo. It also lowered HDL cholesterol, the so-called “good” cholesterol. A 50/50 CLA mixture (the kind found in most supplements) performed somewhat better on glucose metabolism in that study, but still lowered HDL.⁷ A companion analysis from the same research group found that the t10,c12 isomer triggered massive increases in oxidative stress markers and C-reactive protein, an indicator of systemic inflammation. The rise in oxidative stress was independently related to the worsening of insulin resistance.⁸

The picture looks similarly concerning for people with existing type 2 diabetes. A trial of CLA supplementation in diabetic patients found that CLA raised fasting glucose and reduced insulin sensitivity across multiple measurement methods.⁹ Broader reviews have listed insulin resistance and impaired glucose handling among CLA’s documented adverse effects in humans.¹⁰ For anyone with prediabetes, diabetes, or metabolic syndrome, CLA supplementation carries a real and well-documented risk of making blood sugar control worse, and the people most likely to want a fat-loss supplement are often exactly the people most metabolically at risk.

Blood Lipids and Heart Health

If you are hoping CLA might improve your cholesterol numbers, the evidence is not encouraging. A large dose-response meta-analysis of randomized trials found that CLA supplementation did not significantly change triglycerides, total cholesterol, or LDL cholesterol. It did produce a small but statistically significant reduction in HDL cholesterol, which is the opposite of what you would want for cardiovascular protection.¹¹ An earlier trial in healthy adults with normal cholesterol levels had already reached a similar conclusion, finding no changes in any lipoprotein fraction after two months of supplementation.¹²

When it comes to blood pressure and vascular function, a systematic review of 18 randomized trials found that CLA did not significantly alter systolic or diastolic blood pressure.¹³ A six-month trial specifically testing the c9,t11 isomer in overweight adults found no effect on arterial stiffness.¹⁴ And a separate study comparing CLA with safflower oil in overweight men found that CLA did not impair endothelial function, though the CLA group did lose more body weight.¹⁵ The overall cardiovascular picture is essentially neutral: CLA does not appear to harm blood vessels or blood pressure, but it does not help cholesterol levels and may slightly worsen the HDL profile.

The Inflammation Question

CLA’s effect on inflammation is genuinely confusing, partly because different meta-analyses of the same body of evidence have reached somewhat different conclusions. A large systematic review pooling data from 42 studies found that CLA supplementation lowered two key inflammatory markers, IL-6 and TNF-alpha, but slightly increased C-reactive protein (CRP).¹⁶ An earlier meta-analysis found a more clearly negative pattern, with CLA raising both CRP and TNF-alpha.¹⁷

These discrepancies probably reflect differences in the studies included, the populations studied, and which CLA isomers were used. What seems fairly consistent is that CLA tends to push CRP upward, which aligns with the oxidative stress findings from the insulin resistance research discussed earlier. Whether the reductions in IL-6 and TNF-alpha are large enough to offset the CRP increase is not something the current evidence can cleanly answer. The takeaway for a supplement user is that CLA is not a straightforward anti-inflammatory agent, despite occasional marketing claims to that effect.

CLA for Exercise and Athletic Performance

CLA supplements are sometimes marketed alongside fitness products, implying they help build muscle or enhance training results. The evidence here is thin. A study of experienced resistance-trained athletes found that CLA supplementation did not produce significant changes in fat-free mass, fat mass, body weight, bone mass, or strength during training. The researchers concluded that CLA did not appear to possess meaningful ergogenic value for trained individuals.¹⁸

One context where a combination supplement showed more promise was in older adults. When CLA was combined with creatine monohydrate during a resistance training program, the combination group showed greater improvements in fat-free mass, lower fat mass, and better muscular endurance compared to placebo. Women in the combination group saw particularly large gains in knee extension strength.¹⁹ But because that study combined CLA with creatine, it is impossible to separate how much of the benefit came from each supplement. Creatine alone has a well-established track record for improving strength and lean mass, so attributing the results to CLA specifically would be a stretch.

Bone Density

An emerging area of CLA research involves bone health. Preclinical work, mostly in mice, has found that CLA may help preserve bone mineral density, potentially by tamping down inflammatory signals that drive bone breakdown. The t10,c12 isomer in particular has shown the ability to enhance bone formation and reduce bone resorption in animal models.²⁰ In one study, aging female mice fed CLA maintained higher bone mineral density across multiple bone regions compared to mice on a standard diet, and the CLA-fed mice also showed reduced levels of the inflammatory cytokines that normally accelerate age-related bone loss.²¹

These are intriguing findings, but they have not yet been validated in large human trials. The gap between mice and humans is substantial in bone biology, and the CLA doses used in animal studies often do not translate directly to practical human supplementation. Still, for a fatty acid primarily studied for its effects on body composition, the bone data represent a genuinely different avenue of potential benefit that may warrant future clinical investigation.

CLA and the Gut Microbiome

Some of CLA’s effects may be mediated partly through changes in gut bacteria, though this line of research is still in its early stages and almost entirely conducted in animals. Mice fed CLA on a high-fat diet showed significant increases in specific gut bacterial populations, including a large increase in Akkermansia muciniphila, a species associated with better metabolic health and gut barrier function.²²

A particularly interesting study found that CLA profoundly altered gut microbiome composition in mice prone to a form of autoimmune brain inflammation. The CLA-supplemented mice developed less severe disease. When the researchers temporarily wiped out the gut bacteria with antibiotics, the improvement from CLA persisted even after the microbiome was disrupted, suggesting that CLA’s benefits in that model were not entirely dependent on its microbiome effects but might also involve direct immune modulation.²³ Whether any of this translates to meaningful gut health benefits in people taking standard supplement doses is unknown, but it adds another layer to how CLA interacts with the body beyond simple fat metabolism.

Liver Concerns and Other Side Effects

Beyond the insulin resistance issue, CLA supplements have been linked to a few other adverse effects worth knowing about. One is hepatic steatosis, or fatty liver. This has been documented both in animal studies and flagged as a concern in human contexts, particularly with the t10,c12 isomer.²⁴ The irony is hard to miss: a supplement taken to reduce body fat may promote fat accumulation in the liver, a condition with its own serious health consequences over time.

Common but less alarming side effects reported in clinical trials include gastrointestinal complaints like loose stools, bloating, and nausea, especially at higher doses. These tend to lessen after the first week or two of supplementation. The broader concern is that CLA supplements deliver a 50/50 mixture of isomers by default, and no widely available consumer product lets you select only the c9,t11 isomer (the one that appears safer). The t10,c12 isomer comes along for the ride every time, bringing its metabolic downsides with it.

Natural CLA Versus Synthetic CLA

Eating grass-fed beef or full-fat dairy is a very different proposition than swallowing 3 grams of CLA from a capsule. The CLA in food is overwhelmingly the c9,t11 isomer, arrives in much smaller doses spread across meals, and comes packaged with other fats, proteins, and micronutrients. The CLA in supplements is industrially produced from plant oils and delivers a large bolus of both isomers at once. Feeding studies in cattle have illustrated this divergence neatly: steers raised on pasture had several times more of the natural c9,t11 CLA in their meat, while supplementing cattle with synthetic CLA did not meaningfully increase c9,t11 content but did raise the t10,c12 isomer.²⁵

This is worth keeping in mind when you hear broad claims about CLA’s health benefits. Many of the positive findings from population-level diet studies reflect the effects of food-derived c9,t11 CLA consumed at low doses as part of a complex dietary matrix. Most of the concerning findings on insulin resistance and inflammatory markers come from supplement studies using mixed-isomer products at much higher doses. Treating “CLA” as a single entity obscures the fact that the version in your cheese and the version in your capsule may act quite differently in your body.